General Information of This Linker
Linker ID
LIN0TBXFS
Linker Name
CN119630431A-ADC-29-LINKER
Linker Type
Cathepsin-cleavable linker
Antibody-Linker Relation
Cleavable
Structure
Formula
C27H29N3O8S2
Isosmiles
NC(C[C@H](NC(CCOCCOCCN1C(C(SC2=CC=CC=C2)=C(SC3=CC=CC=C3)C1=O)=O)=O)C(O)=O)=O
InChI
InChI=1S/C27H29N3O8S2/c28-21(31)17-20(27(35)36)29-22(32)11-13-37-15-16-38-14-12-30-25(33)23(39-18-7-3-1-4-8-18)24(26(30)34)40-19-9-5-2-6-10-19/h1-10,20H,11-17H2,(H2,28,31)(H,29,32)(H,35,36)/t20-/m0/s1
InChIKey
PDFHOSUQGZQUDM-FQEVSTJZSA-N
Pharmaceutical Properties
Molecule Weight
587.676
Polar area
165.33
Complexity
1123.614127
xlogp Value
2.0195
Heavy Count
40
Rot Bonds
17
Hbond acc
9
Hbond Donor
3
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
WO2024043319A1 18 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.047 nM
Positive CEACAM6_#84.7 expression (CEACAM6_#84.7 +++/++)
Method Description
In vitro cytotoxicity of ADCs in AsPC-1 cells.
In Vitro Model Pancreatic ductal adenocarcinoma AsPC-1 cells CVCL_0152
References
Ref 1 Antibody-drug complexes